Prosecution Insights
Last updated: November 11, 2026

Opticept Technologies AB

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Opticept Technologies AB has 1 pending office action in Biotechnology & Pharmaceuticals. PAK, JOHN D is identified as the busiest examiner, and the examination record is concentrated in a single examiner and art-unit setting. The profile gives the company a defined prosecution channel for its biotechnology and pharmaceutical subject matter.

The response should connect the claims to the disclosed biological mechanism, composition, or process and address the examiner’s specific grounds with evidence appropriate to the technology. A focused assignment can support consistent terminology across the response and later amendments. The data does not show multiple examination groups, so counsel can prioritize direct resolution of the recorded action rather than broader coordination across separate prosecution teams.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAK, JOHN D 1 52.4% +37.9%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18030739 A METHOD FOR TREATING A BIOLOGICAL MATERIAL PAK, JOHN D 51d overdue

Top Art Units

Art UnitApps
1699 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18030739 A METHOD FOR TREATING A BIOLOGICAL MATERIAL PAK, JOHN D 1699 §103§112DP Non-Final OA 51d overdue Pending Apr 06, 2023

Managing Opticept Technologies AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Opticept Technologies AB have?

Opticept Technologies AB has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Opticept Technologies AB applications?

John D Pak has the most, with 1 of Opticept Technologies AB's pending office actions.

What technology area are Opticept Technologies AB's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month